Novartis Ag ADR (NVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2004 | 12-2003 | 12-2002 | 12-2001 | 12-2000 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,083,000 | 5,646,000 | 5,798,000 | 6,635,000 | 6,635,000 |
| Marketable Securities | 7,809,000 | 7,613,000 | 6,744,000 | 6,367,000 | 6,367,000 |
| Receivables | 4,851,000 | 4,376,000 | 3,697,000 | 3,184,000 | 3,184,000 |
| Inventories | 3,558,000 | 3,346,000 | 2,963,000 | 2,448,000 | 2,448,000 |
| Other current assets | 1,619,000 | 1,292,000 | 1,613,000 | 1,723,000 | 1,723,000 |
| TOTAL | $23,920,000 | $22,273,000 | $20,815,000 | $20,357,000 | $20,357,000 |
| Non-Current Assets | |||||
| PPE Net | 8,497,000 | 7,597,000 | 6,321,000 | 5,393,000 | 5,393,000 |
| Investments And Advances | 7,450,000 | 6,848,000 | 6,483,000 | 3,997,000 | 3,997,000 |
| Intangibles | 5,629,000 | 4,708,000 | 4,395,000 | 0 | 0 |
| Other Non-Current Assets | 6,992,000 | 7,891,000 | 7,011,000 | 10,006,000 | 10,006,000 |
| TOTAL | $28,568,000 | $27,044,000 | $24,210,000 | $19,396,000 | $19,396,000 |
| Total Assets | $52,488,000 | $49,317,000 | $45,025,000 | $39,753,000 | $39,753,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 4,119,000 | 2,779,000 | 2,841,000 | 0 | 3,020,000 |
| Accounts payable and accrued liabilities | 2,020,000 | 1,665,000 | 1,266,000 | 1,077,000 | 1,077,000 |
| Other current liabilities | 4,609,000 | 4,876,000 | 4,165,000 | 4,373,000 | 4,373,000 |
| TOTAL | $11,849,000 | $9,320,000 | $8,272,000 | $8,470,000 | $8,470,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 2,736,000 | 3,191,000 | 2,729,000 | 1,483,000 | 1,483,000 |
| Other Non-Current Liabilities | 4,233,000 | 3,105,000 | 2,854,000 | 2,330,000 | 2,342,000 |
| TOTAL | $9,324,000 | $9,478,000 | $8,418,000 | $6,137,000 | $6,137,000 |
| Total Liabilities | $21,173,000 | $18,798,000 | $16,690,000 | $14,607,000 | $14,607,000 |
| Shareholders' Equity | |||||
| Common Shares | 1,008,000 | 1,017,000 | 1,025,000 | 859,000 | 859,000 |
| Retained earnings | 30,328,000 | 29,533,000 | 27,371,000 | 24,387,000 | 0 |
| Other shareholders' equity | 138,000 | 90,000 | 66,000 | 0 | 24,387,000 |
| TOTAL | $31,315,000 | $30,519,000 | $28,335,000 | $25,146,000 | $25,146,000 |
| Total Liabilities And Equity | $52,488,000 | $49,317,000 | $45,025,000 | $39,753,000 | $39,753,000 |